Additionally, 43.2% of patients on the high dose reported nausea and 33.1% reported diarrhea, compared with 10.7% and 13.4% in the placebo group
Mounjaro (tirzepatide) is a similar option for Type 2 diabetes that is classified as a dual GIP/GLP-1 receptor agonist
This isnt just misleadingits irresponsible
, 63 , 186-193, doi: Xie, X., Zhao, Y., Ma, C
Both compounds are studied in research models for activity at tissue-repair, angiogenesis, and cellular migration signaling pathways
Relax Dont smoke Get more exercise Learn how to reduce and manage stress in your life Limit or avoid consumption of gluten and dairy Eat small meals throughout the day Keep a food diary to figure out which foods trigger IBS symptoms The second thing is to consider which medications and supplements can also help you manage IBS symptoms